OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria
Stian Foss, Siri A. Sakya, Leire Aguinagalde, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13

Showing 13 citing articles:

Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress
Torleif Tollefsrud Gjølberg, Simone Mester, Gaia Calamera, et al.
BioDrugs (2025)
Open Access

Lessons for Medical Countermeasure Development from Unforeseen Outbreaks
Marie Mura, Aurélie Trignol, E. Le Dault, et al.
Emerging Microbes & Infections (2025)
Open Access

Effect of FcRn Binding on Monoclonal Antibody Disposition in the Brain
Hsien Wei Huang, Shengjia Wu, Shufang Liu, et al.
The AAPS Journal (2025) Vol. 27, Iss. 3
Open Access

Next-Generation Therapeutic Antibodies for Cancer Treatment: Advancements, Applications, and Challenges
A. Raja, Abhishek Kasana, Vaishali Verma
Molecular Biotechnology (2024)
Closed Access | Times Cited: 3

Selection and characterization of a peptide-based complement modulator targeting C1 of the innate immune system
Sebastiaan M. W. R. Hamers, Leoni Abendstein, Aimee L. Boyle, et al.
RSC Chemical Biology (2024) Vol. 5, Iss. 8, pp. 787-799
Open Access | Times Cited: 1

Trade-off between the antiviral and vaccinal effects of antibody therapy in the humoral response to HIV
Soumya Mittal, Amar K. Garg, Rajat Desikan, et al.
Journal of The Royal Society Interface (2024) Vol. 21, Iss. 221
Closed Access | Times Cited: 1

Enhancing complement activation by therapeutic anti-tumor antibodies: Mechanisms, strategies, and engineering approaches
Vitalijs Ovcinnikovs, Karin Dijkman, Gijs G. Zom, et al.
Seminars in Immunology (2024) Vol. 77, pp. 101922-101922
Open Access | Times Cited: 1

Engineered IgG Fc-conjugation prolongs the half-life of florfenicol and alleviates pneumonia in mice
Shikun Ge, Mei Dang, Alberto Carlos Pires Dias, et al.
Biochimie (2024)
Closed Access

Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biases
Maria Chernigovskaya, Khang Lê Quý, Maria Stensland, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Plant‐produced SARSCoV‐2 antibody engineered towards enhanced potency and in vivo efficacy
Steven W. de Taeye, Loı̈c Faye, Bertrand Morel, et al.
Plant Biotechnology Journal (2024)
Open Access

Human IgG Subclasses Differ in the Structural Elements of Their N-Glycosylation
Wei‐Wei Wang, Joshua C. L. Maliepaard, Timon Damelang, et al.
ACS Central Science (2024) Vol. 10, Iss. 11, pp. 2048-2058
Open Access

Single-cell Sequencing of Circulating Human Plasmablasts during Staphylococcus aureus Bacteremia
Priscilla F. Kerkman, Lisanne de Vor, Thomas W. van der Vaart, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 11, pp. 1644-1655
Closed Access

Page 1

Scroll to top